<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03910400</url>
  </required_header>
  <id_info>
    <org_study_id>16CR3034B</org_study_id>
    <nct_id>NCT03910400</nct_id>
  </id_info>
  <brief_title>Early Assessment of QFR in STEMI-II</brief_title>
  <acronym>EARLYmyoQFR-II</acronym>
  <official_title>EARLY Microvascular Dysfunction Assessment Using Quantitative Flow Ratio After ST-segment Elevation MYOcardial Infarction (EARLY-MYO-QFR II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study intends to provide new data on whether the noval method using quantitative flow
      ratio could assess microvascular dysfunction based on the previous study EARLY-MYO-QFR-I.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Microvascular dysfunction (MVD) is a serious complication of PCI, which happens frequently
      after STEMI and always correlates with a poor prognosis. However, precise and simplified
      assessment of MVD is difficult, especially in the acute phase of STEMI patients. Resent
      studies suggested that FFR could be overestimated when MVD exists. But whether the
      overestimated value of FFR caused by CMR defined microvascular obstruction (MVO) could
      reflect microvascular function is still unclear.

      In the previous study EARLY-MYO-QFR-I, we have demonstrated that the relationship between
      Contrast-enhanced CMR defined MVO and QFR. While angiography images were collected on a
      retrospectively manner, and the study population were selected (STEMI patients with
      spontaneously recanalized culprit vessel before PCI) to verify our hypothesis.

      This phase of study would be a prospective study. We tend to created a new study population
      by a temporary artificial stenosis inside the stent by partially inflating a balloon catheter
      during pharmacologic hyperemia in STEMI patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac magnetic resonance (CMR)</measure>
    <time_frame>Five days after PCI</time_frame>
    <description>Cardiac magnetic resonance (CMR) is a non-invasive test for MVO assessing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TIMI Flow Grade (TFG)</measure>
    <time_frame>One minutes after PCI</time_frame>
    <description>TIMI Flow Grade (TFG) assesses flow in the epicardial arteries. Type zero perfusion expressed not antegrade movement away the occlusion; type two is a minimum, inadequate perfusion of contrast average round the mass; type three (partial perfusion) is a perfect just limited perfusion from the distal coronary bed by contrast element; and type three (complete perfusion) is an antegrade movement to the whole distal artery at a regular flow.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TIMI Myocardial Perfusion Grade (TMPG)</measure>
    <time_frame>One minutes after PCI</time_frame>
    <description>TIMI Myocardial Perfusion Grade (TMPG) assesses flow in the microvessels. TMPG0: no or minimal blush; TMPG1: Stain present Blush persists on next injection; TMPG2: Dye strongly persistent at end of washout Gone by next injection; TMPG3: normal ground glass appearance of blush Dye mildly persistent at end of washout.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ST-segment resolution (STR)</measure>
    <time_frame>90 minutes after PCI</time_frame>
    <description>The ST-segment resolution (STR) was measured after the end of the QRS complex J point in leads I, aVL, and V1 to V6 for anterior MI, and leads II, III, aVF, V5, and V6 for nonanterior MI.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>ST Segment Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>MVO group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CMR was performed in all the cases. According to the results of CMR, we divided the study population into MVO group and Non-MVO group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-MVO group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CMR was performed in all the cases. According to the results of CMR, we divided the study population into MVO group and Non-MVO group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Computation of quantitative flow ratio</intervention_name>
    <description>After stents were implanted whenever technically possible in the STEMI patients, the investigators created a temporary artificial stenosis inside the stent by partially inflating a balloon catheter during pharmacologic hyperemia.
Computation of QFR was performed offline, using AngioPlus system(Pluse medical imaging technology, Shanghai, China). In the first step, 2 diagnostic angiographic projections with the artifical stenosis, at least 25Â° apart, were selected and 3D reconstruction of the interrogated vessel without its side branches was performed. Then, the software computed the QFR.</description>
    <arm_group_label>MVO group</arm_group_label>
    <arm_group_label>Non-MVO group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  STEMI patients treated with revasculation within 12 hours from onset of symptoms to
             PCI time and received CMR 5 days afterwards. STEMI was defined as a combination of the
             following: chest pain for more than 30min, electrocardiographic (ECG) changing with ST
             segment elevation of &gt;2 mm in at least 2 precordial leads and &gt;1 mm in limb leads, and
             abnormal troponin levels or CKMB levels higher than twice the upper limit of normal.

          -  Stents were implanted whenever technically possible.

          -  TFG 2/3 after PCI.

        Exclusion Criteria:

          -  Patients with left bundle branch block in the presenting ECG, cardiogenic shock,
             previous PCI or bypass surgery, previous AMI history.

          -  Patients with trouble in partially inflating a balloon catheter during pharmacologic
             hyperemia.

          -  Patients with unqualified coronary angiographic images with problems such as ostial
             lesion, severe vessel tortuosity and diffuse long lesions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jun Pu, MD,PhD</last_name>
    <phone>86-21-68383477</phone>
    <email>pujun310@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Pu</last_name>
      <phone>86-21-68383477</phone>
      <email>pujun310@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009 Jul 21;54(4):281-92. doi: 10.1016/j.jacc.2009.03.054. Review.</citation>
    <PMID>19608025</PMID>
  </reference>
  <reference>
    <citation>Sheng X, Ding S, Ge H, Sun Y, Kong L, He J, Pu J, He B. Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon. Int J Cardiol. 2018 Aug 15;265:6-11. doi: 10.1016/j.ijcard.2018.04.119. Epub 2018 Apr 25.</citation>
    <PMID>29728334</PMID>
  </reference>
  <reference>
    <citation>Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003 Jul 1;107(25):3129-32. Epub 2003 Jun 23. Erratum in: Circulation. 2003 Dec 23;108(25):3165.</citation>
    <PMID>12821539</PMID>
  </reference>
  <reference>
    <citation>Fearon WF, Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008 Feb 5;51(5):560-5. doi: 10.1016/j.jacc.2007.08.062.</citation>
    <PMID>18237685</PMID>
  </reference>
  <reference>
    <citation>Fearon WF, Low AF, Yong AC, McGeoch R, Berry C, Shah MG, Ho M, Kim HS, Loh JP, Oldroyd KG. Response to letter regarding article, &quot;Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention&quot;. Circulation. 2014 Feb 18;129(7):e342. doi: 10.1161/CIRCULATIONAHA.113.007271.</citation>
    <PMID>24550557</PMID>
  </reference>
  <reference>
    <citation>van de Hoef TP, Nolte F, EchavarrÃa-Pinto M, van Lavieren MA, Damman P, Chamuleau SA, Voskuil M, Verberne HJ, Henriques JP, van Eck-Smit BL, Koch KT, de Winter RJ, Spaan JA, Siebes M, Tijssen JG, Meuwissen M, Piek JJ. Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment. Heart. 2014 Jun;100(12):951-9. doi: 10.1136/heartjnl-2013-305124. Epub 2014 Apr 11.</citation>
    <PMID>24727867</PMID>
  </reference>
  <reference>
    <citation>Tu S, Echavarria-Pinto M, von Birgelen C, Holm NR, Pyxaras SA, Kumsars I, Lam MK, Valkenburg I, Toth GG, Li Y, Escaned J, Wijns W, Reiber JH. Fractional flow reserve and coronary bifurcation anatomy: a novel quantitative model to assess and report the stenosis severity of bifurcation lesions. JACC Cardiovasc Interv. 2015 Apr 20;8(4):564-74. doi: 10.1016/j.jcin.2014.12.232. Epub 2015 Mar 26.</citation>
    <PMID>25819180</PMID>
  </reference>
  <reference>
    <citation>Emori H, Kubo T, Kameyama T, Ino Y, Matsuo Y, Kitabata H, Terada K, Katayama Y, Aoki H, Taruya A, Shimamura K, Ota S, Tanaka A, Hozumi T, Akasaka T. Diagnostic Accuracy of Quantitative Flow Ratio for Assessing Myocardial Ischemia in Prior Myocardial Infarction. Circ J. 2018 Feb 23;82(3):807-814. doi: 10.1253/circj.CJ-17-0949. Epub 2018 Jan 16.</citation>
    <PMID>29343675</PMID>
  </reference>
  <reference>
    <citation>Spitaleri G, Tebaldi M, Biscaglia S, Westra J, Brugaletta S, Erriquez A, Passarini G, Brieda A, Leone AM, Picchi A, Ielasi A, Girolamo DD, Trani C, Ferrari R, Reiber JHC, Valgimigli M, SabatÃ¨ M, Campo G. Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease. Circ Cardiovasc Interv. 2018 Feb;11(2):e006023. doi: 10.1161/CIRCINTERVENTIONS.117.006023.</citation>
    <PMID>29449325</PMID>
  </reference>
  <reference>
    <citation>Tu S, Westra J, Yang J, von Birgelen C, Ferrara A, Pellicano M, Nef H, Tebaldi M, Murasato Y, Lansky A, Barbato E, van der Heijden LC, Reiber JH, Holm NR, Wijns W; FAVOR Pilot Trial Study Group. Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study. JACC Cardiovasc Interv. 2016 Oct 10;9(19):2024-2035. doi: 10.1016/j.jcin.2016.07.013.</citation>
    <PMID>27712739</PMID>
  </reference>
  <reference>
    <citation>Pu J, Ding S, Ge H, Han Y, Guo J, Lin R, Su X, Zhang H, Chen L, He B; EARLY-MYO Investigators. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27. Erratum in: Circulation. 2018 Feb 13;137(7):e29.</citation>
    <PMID>28844990</PMID>
  </reference>
  <reference>
    <citation>Cuculi F, De Maria GL, Meier P, Dall'Armellina E, de Caterina AR, Channon KM, Prendergast BD, Choudhury RP, Forfar JC, Kharbanda RK, Banning AP. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014 Nov 4;64(18):1894-904. doi: 10.1016/j.jacc.2014.07.987. Epub 2014 Oct 27. Erratum in: J Am Coll Cardiol. 2015 Mar 3;65(8):866. Choudhury, Robin C [Corrected to Choudhury, Robin P].</citation>
    <PMID>25444143</PMID>
  </reference>
  <reference>
    <citation>MejÃ­a-RenterÃ­a H, Lee JM, Lauri F, van der Hoeven NW, de Waard GA, Macaya F, PÃ©rez-Vizcayno MJ, Gonzalo N, JimÃ©nez-Quevedo P, Nombela-Franco L, Salinas P, NÃºÃ±ez-Gil I, Del Trigo M, Goto S, Lee HJ, Liontou C, FernÃ¡ndez-Ortiz A, Macaya C, van Royen N, Koo BK, Escaned J. Influence of Microcirculatory Dysfunction on Angiography-Based Functional Assessment of Coronary Stenoses. JACC Cardiovasc Interv. 2018 Apr 23;11(8):741-753. doi: 10.1016/j.jcin.2018.02.014.</citation>
    <PMID>29673505</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 9, 2019</study_first_submitted>
  <study_first_submitted_qc>April 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2019</study_first_posted>
  <last_update_submitted>April 8, 2020</last_update_submitted>
  <last_update_submitted_qc>April 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STEMI</keyword>
  <keyword>Cardiac magnetic resonance</keyword>
  <keyword>balloon catheter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

